+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Body Composition Analyzer Market - Global Forecast 2026-2032- Product Image
Body Composition Analyzer Market - Global Forecast 2026-2032- Product Image
Sale

Body Composition Analyzer Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • July 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011017
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Body Composition Analyzer Market is projected to reach USD 901.73 Million in 2026. It is expected to continue growing at a CAGR of 9.10%, reaching USD 1.52 Billion by 2032.

Body composition analyzers are moving from niche fitness and clinical tools into a broader ecosystem of preventive healthcare, sports performance, obesity management, metabolic health, corporate wellness, and remote patient monitoring. Unlike conventional weight scales, these systems assess parameters such as body fat percentage, skeletal muscle mass, visceral fat, total body water, segmental composition, basal metabolic indicators, and body mass index, helping clinicians, trainers, researchers, and consumers interpret health status with greater context. Demand is being shaped by the documented global burden of obesity, diabetes, cardiovascular disease, sarcopenia, and lifestyle-related metabolic disorders, alongside rising interest in personalized nutrition and precision wellness. Technologies including bioelectrical impedance analysis, dual-energy X-ray absorptiometry, air displacement plethysmography, skinfold measurement, and 3D optical scanning are being adopted across hospitals, diagnostic centers, gyms, sports institutes, research settings, and home wellness environments. The industry’s strategic direction is increasingly defined by accuracy, usability, interoperability, data security, and clinical validation, as users seek actionable insights rather than standalone measurements.

Transformative Shifts in the Body Composition Analyzer Landscape

The body composition analyzer landscape is undergoing a structural shift from isolated measurement devices to connected, software-enabled health intelligence platforms. Healthcare providers are using body composition data to support obesity treatment, nutrition therapy, rehabilitation, geriatric care, renal care, and cardiometabolic risk evaluation. Fitness and wellness settings are adopting analyzers to monitor muscle gain, fat loss, hydration, and training effectiveness, while consumers increasingly expect app-based tracking and personalized recommendations. This shift is reinforced by wider adoption of digital health records, telehealth workflows, wearable devices, and preventive care models. Another major transformation is the movement toward non-invasive, rapid, and portable analysis, making body composition assessment more accessible outside hospitals. At the same time, regulatory and clinical expectations are increasing, particularly around measurement repeatability, calibration, population-specific algorithms, and transparency in data interpretation. As the industry matures, success depends on combining technical precision with user-friendly reporting, seamless data exchange, and evidence-based health guidance.

Cumulative Impact of Artificial Intelligence on Body Composition Analysis

Artificial intelligence is becoming a decisive force in body composition analysis by improving interpretation, personalization, workflow efficiency, and longitudinal monitoring. AI-enabled systems can help identify patterns in body fat distribution, muscle imbalance, hydration trends, and risk indicators when combined with age, sex, activity, medical history, and lifestyle inputs. In clinical and wellness environments, machine learning can support automated report generation, anomaly detection, progress tracking, and tailored recommendations for nutrition, exercise, rehabilitation, and chronic disease management. AI also supports image-based and sensor-driven approaches, including 3D body scanning and multi-frequency impedance analytics, where algorithms can refine segmentation and trend assessment. However, the cumulative impact of AI depends on responsible deployment. Models must be trained and validated on diverse populations to reduce bias, and outputs should be explainable, clinically relevant, and compliant with privacy and health data regulations. Industry leaders that prioritize validated algorithms, secure cloud infrastructure, and transparent decision support are best positioned to translate AI into measurable user value.

Key Regional Insights Across Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

Asia-Pacific is experiencing strong adoption momentum as urbanization, rising fitness participation, growing diabetes prevalence, and expanding private healthcare infrastructure drive demand for body composition assessment across China, India, Japan, South Korea, Australia, and ASEAN economies. North America remains a highly developed environment for advanced body composition analyzers, supported by established obesity management programs, sports science facilities, digital health adoption, and widespread use in hospitals, fitness centers, and research institutions. Latin America is seeing increased use in clinical nutrition, wellness centers, and preventive health programs, particularly where obesity, metabolic syndrome, and lifestyle-related diseases are public health priorities. Europe is characterized by strong clinical governance, research-driven adoption, and demand for validated, privacy-compliant devices across hospitals, universities, rehabilitation settings, and fitness facilities. The Middle East is adopting body composition technologies through premium healthcare expansion, wellness tourism, sports performance initiatives, and public health strategies focused on noncommunicable disease prevention. Africa presents a developing opportunity shaped by gradual healthcare modernization, urban wellness growth, and rising awareness of nutrition-related health conditions, although access, affordability, and infrastructure variability influence adoption patterns across countries.

Key Group Insights Covering ASEAN, GCC, European Union, BRICS, G7, and NATO

Within ASEAN, body composition analyzers are gaining relevance as governments and private providers address rising rates of obesity, diabetes, and sedentary lifestyle risks while fitness chains and wellness clinics expand across urban centers. GCC countries are integrating body composition assessment into preventive care, sports performance, premium wellness, and national health initiatives targeting chronic disease reduction, with adoption supported by advanced hospital infrastructure and high healthcare investment intensity. The European Union emphasizes validated medical technology, interoperability, data protection, and evidence-based clinical use, making compliance, accuracy, and privacy central to analyzer adoption. BRICS economies present diverse but significant demand drivers, including large populations, expanding middle classes, growing diagnostic infrastructure, and increasing attention to obesity, malnutrition, aging, and sports performance. G7 markets are characterized by mature healthcare systems, high consumer health awareness, advanced research environments, and strong adoption of connected wellness technologies. NATO member countries overlap significantly with developed healthcare and defense-related performance monitoring ecosystems, where body composition data can support military readiness, occupational health, rehabilitation, and preventive wellness programs.

Key Country Insights Across Major Body Composition Analyzer Markets

The United States demonstrates broad use of body composition analyzers in clinical obesity care, sports medicine, fitness, academic research, and consumer wellness, supported by strong digital health adoption and heightened awareness of metabolic disease risk. Canada shows steady integration across healthcare, rehabilitation, and wellness settings, with emphasis on preventive care and chronic disease management. Mexico and Brazil are increasingly focused on obesity, diabetes, and lifestyle-related health burdens, supporting the use of body composition assessment in nutrition, fitness, and clinical programs. The United Kingdom, Germany, France, Italy, and Spain reflect Europe’s evidence-driven approach, where validated devices are used in hospitals, research institutions, sports performance centers, and wellness facilities while data protection and clinical accuracy remain important procurement factors. Russia shows demand across sports science, rehabilitation, medical diagnostics, and institutional health programs. China is rapidly expanding adoption through fitness technology, hospital modernization, preventive healthcare, and digital wellness platforms, while India’s demand is supported by diabetes prevalence, urban fitness growth, and rising preventive health awareness. Japan and South Korea show strong uptake driven by aging populations, advanced medical technology ecosystems, body weight management culture, and consumer electronics integration. Australia combines clinical, sports science, and wellness use cases, with demand reinforced by preventive healthcare priorities, active lifestyles, and high interest in personalized health monitoring.

Actionable Recommendations for Body Composition Analyzer Industry Leaders

Industry leaders should prioritize clinically validated accuracy, repeatable measurements, and clear interpretation across diverse age groups, ethnicities, body types, and health conditions. Product strategies should emphasize connected platforms that integrate with electronic health records, fitness apps, telehealth systems, and wearable ecosystems while maintaining strong cybersecurity and privacy safeguards. Manufacturers and solution providers should develop segmented offerings for hospitals, diagnostic centers, gyms, sports institutes, nutrition clinics, corporate wellness programs, and home users rather than relying on one-size-fits-all positioning. AI capabilities should be introduced with transparent model logic, documented validation, and human-in-the-loop decision support to build trust among clinicians and end users. Regional strategies should account for differences in regulatory requirements, reimbursement environments, infrastructure maturity, and user affordability. Training and education are also essential, as proper electrode placement, hydration control, testing protocols, and longitudinal interpretation directly affect reliability. Partnerships with healthcare providers, fitness professionals, academic institutions, and public health programs can strengthen credibility and expand responsible adoption.

Research Methodology for Evidence-Based Industry Analysis

This executive summary is developed through a structured secondary research approach using verified, publicly available, and data-backed sources, including healthcare agencies, public health organizations, regulatory guidance, clinical literature, industry standards, peer-reviewed studies, and regional health statistics. The analysis evaluates technology trends, application areas, adoption drivers, regulatory considerations, disease-burden indicators, digital health integration, and end-user behavior across regions, economic groups, and priority countries. Insights are synthesized qualitatively to identify strategic patterns without presenting market size, market share, estimation, or forecasting. The methodology emphasizes triangulation across multiple credible sources to reduce reliance on single-point evidence and to ensure that findings reflect real-world healthcare, fitness, wellness, and research use cases. Special attention is given to obesity, diabetes, aging, sarcopenia, preventive health, sports performance, and remote monitoring trends because these factors directly influence the adoption and value proposition of body composition analyzers.

Conclusion: Body Composition Analysis as a Foundation for Personalized Health

Body composition analyzers are becoming essential tools in the transition from reactive weight measurement to proactive health intelligence. Their value lies in translating fat, muscle, water, and segmental composition data into practical decisions for clinical care, wellness planning, sports performance, nutrition, rehabilitation, and chronic disease prevention. The industry is being reshaped by connected devices, AI-enabled insights, portable assessment, consumer health engagement, and stronger expectations for validation and data protection. Regional opportunities vary widely, but the common direction is clear: stakeholders increasingly need accurate, accessible, and interpretable body composition data to support personalized health outcomes. Organizations that combine scientific credibility, digital integration, privacy-by-design, and user-centered reporting will be best positioned to capture long-term relevance in this evolving field.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Body Composition Analyzer Market, by Analyzer Type
7.1. Introduction
7.2. Air Displacement Plethysmography
7.3. Bioelectrical Impedance Analysis (BIA)
7.4. Dual-Energy X-Ray Absorptiometry (DXA)
7.4.1. Fan-Beam DXA
7.4.2. Pencil-Beam DXA
7.5. Hydrostatic Weighing Systems
7.6. Magnetic Resonance Imaging (MRI) Analyzers
7.7. Ultrasound-Based Composition
8. Body Composition Analyzer Market, by Modality
8.1. Introduction
8.2. Portable Devices
8.2.1. Handheld
8.2.2. Wearable
8.3. Standalone Devices
9. Body Composition Analyzer Market, by Measurement Type
9.1. Introduction
9.2. Multi-frequency Analysis
9.3. Segmental Analysis
9.4. Single-frequency Analysis
9.5. Whole-body Analysis
10. Body Composition Analyzer Market, by Parameter Measured
10.1. Introduction
10.2. Basal Metabolic Rate (BMR)
10.3. Body Fat Percentage
10.4. Body Mass Index (BMI)
10.5. Body Water Content
10.6. Bone Mineral Density
10.7. Fat-free Mass
10.8. Metabolic Age
10.9. Muscle Mass
10.10. Protein Mass
10.11. Skeletal Muscle Mass
10.12. Visceral Fat Level
11. Body Composition Analyzer Market, by Connectivity
11.1. Introduction
11.2. Bluetooth
11.3. Cloud-connected Systems
11.4. USB
11.5. Wi-Fi
12. Body Composition Analyzer Market, by Distribution Channel
12.1. Introduction
12.2. Offline Channel
12.3. Online Channel
12.3.1. Company Website
12.3.2. eCommerce Website
13. Body Composition Analyzer Market, by Application
13.1. Introduction
13.2. Chronic Disease Management
13.2.1. Cardiology & Heart Failure
13.2.2. Diabetes Management
13.2.3. Oncology & Cachexia
13.2.4. Renal Care
13.3. Nutrition & Dietetics
13.4. Obesity & Weight Management
13.5. Pediatric Growth Assessment
13.6. Population Health Screening
13.7. Preoperative & Postoperative Assessment
13.7.1. Bariatric Surgery
13.7.2. Rehabilitation
13.8. Remote Monitoring
13.9. Sarcopenia & Frailty Screening
13.10. Sports Performance & Training
14. Body Composition Analyzer Market, by End User
14.1. Introduction
14.2. Corporate & Commercial
14.3. Fitness & Wellness Centers
14.4. Healthcare & Medical Facilities
14.4.1. Clinics
14.4.1.1. Bariatric & Weight Management Clinics
14.4.1.2. Endocrinology Clinics
14.4.1.3. Nutrition & Dietetics Clinics
14.4.1.4. Rehabilitation Clinics
14.4.2. Diagnostic Centers
14.4.3. Hospitals
14.5. Home & Individual Users
14.6. Public Health & Government Organizations
14.7. Research & Academic Institutions
14.8. Sports & Performance Institutions
15. Body Composition Analyzer Market, by Region
15.1. Asia-Pacific
15.2. Europe
15.3. North America
15.4. Africa
15.5. Latin America
15.6. Middle East
16. Body Composition Analyzer Market, by Group
16.1. NATO
16.2. G7
16.3. European Union
16.4. BRICS
16.5. ASEAN
16.6. GCC
17. Body Composition Analyzer Market, by Country
17.1. United States
17.2. China
17.3. Germany
17.4. Japan
17.5. India
17.6. United Kingdom
17.7. France
17.8. Canada
17.9. Australia
17.10. Italy
17.11. South Korea
17.12. Russia
17.13. Brazil
17.14. Mexico
17.15. Spain
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. FPNV Positioning Matrix, 2025
18.3. Market Concentration Analysis, 2025
18.3.1. Concentration Ratio (CR)
18.3.2. Herfindahl Hirschman Index (HHI)
18.4. Recent Developments & Impact Analysis, 2025
18.5. Product Portfolio Analysis, 2025
18.6. Benchmarking Analysis, 2025
19. Company Profiles
19.1. A&D Company, Limited
19.2. AccuFitness, LLC
19.3. ACCUNIQ by SELVAS Healthcare, Inc.
19.4. AKERN SRL
19.5. anovator
19.6. Beurer GmbH
19.7. BioTekna Limited.
19.8. Biowave Healthcare
19.9. Bodivis by Tongyong Tizhi Health Technology Co.,Ltd
19.10. Bodystat Limited
19.11. Charder Electronic Co. Ltd
19.12. COSMED Srl
19.13. GE Healthcare, Inc.
19.14. Hologic, Inc.
19.15. Hume Health LLC
19.16. iHealth Labs Inc.
19.17. ImpediMed Limited
19.18. Inbody Co. Ltd.
19.19. Jawon Medical Co., Ltd.
19.20. Joicom Corporation d/b/a Renpho
19.21. medisana GmbH
19.22. Omron Corporation
19.23. RJL Systems, Inc.
19.24. Seca GmbH & Co. KG
19.25. Shenzhen Sonka Medical Technology Co., Limited
19.26. Tanita Corporation
19.27. Terraillon S.A.
19.28. Zimed Healthcare LLC
List of Figures
FIGURE 1. GLOBAL BODY COMPOSITION ANALYZER MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BODY COMPOSITION ANALYZER MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BODY COMPOSITION ANALYZER MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BODY COMPOSITION ANALYZER MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY ANALYZER TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY ANALYZER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY MODALITY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY MEASUREMENT TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY MEASUREMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY PARAMETER MEASURED, 2025 VS 2032 (%)
FIGURE 13. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY PARAMETER MEASURED, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY CONNECTIVITY, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY CONNECTIVITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 25. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 27. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. GLOBAL BODY COMPOSITION ANALYZER MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 29. GLOBAL BODY COMPOSITION ANALYZER MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL BODY COMPOSITION ANALYZER MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL AIR DISPLACEMENT PLETHYSMOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL AIR DISPLACEMENT PLETHYSMOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL AIR DISPLACEMENT PLETHYSMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BIOELECTRICAL IMPEDANCE ANALYSIS (BIA) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BIOELECTRICAL IMPEDANCE ANALYSIS (BIA) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BIOELECTRICAL IMPEDANCE ANALYSIS (BIA) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DUAL-ENERGY X-RAY ABSORPTIOMETRY (DXA) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DUAL-ENERGY X-RAY ABSORPTIOMETRY (DXA) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DUAL-ENERGY X-RAY ABSORPTIOMETRY (DXA) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL FAN-BEAM DXA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL FAN-BEAM DXA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL FAN-BEAM DXA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PENCIL-BEAM DXA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PENCIL-BEAM DXA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PENCIL-BEAM DXA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL HYDROSTATIC WEIGHING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL HYDROSTATIC WEIGHING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL HYDROSTATIC WEIGHING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL MAGNETIC RESONANCE IMAGING (MRI) ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ULTRASOUND-BASED COMPOSITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ULTRASOUND-BASED COMPOSITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ULTRASOUND-BASED COMPOSITION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PORTABLE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PORTABLE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PORTABLE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL HANDHELD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HANDHELD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL HANDHELD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL WEARABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL WEARABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL WEARABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL STANDALONE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL STANDALONE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL STANDALONE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY MEASUREMENT TYPE, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MULTI-FREQUENCY ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MULTI-FREQUENCY ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL MULTI-FREQUENCY ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL SEGMENTAL ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL SEGMENTAL ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL SEGMENTAL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL SINGLE-FREQUENCY ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL SINGLE-FREQUENCY ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL SINGLE-FREQUENCY ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL WHOLE-BODY ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL WHOLE-BODY ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL WHOLE-BODY ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY PARAMETER MEASURED, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BASAL METABOLIC RATE (BMR) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BASAL METABOLIC RATE (BMR) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BASAL METABOLIC RATE (BMR) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BODY FAT PERCENTAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BODY FAT PERCENTAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BODY FAT PERCENTAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BODY MASS INDEX (BMI) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BODY MASS INDEX (BMI) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BODY MASS INDEX (BMI) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BODY WATER CONTENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BODY WATER CONTENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BODY WATER CONTENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BONE MINERAL DENSITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BONE MINERAL DENSITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BONE MINERAL DENSITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL FAT-FREE MASS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL FAT-FREE MASS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL FAT-FREE MASS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL METABOLIC AGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL METABOLIC AGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL METABOLIC AGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL MUSCLE MASS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL MUSCLE MASS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL MUSCLE MASS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PROTEIN MASS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PROTEIN MASS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PROTEIN MASS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL SKELETAL MUSCLE MASS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL SKELETAL MUSCLE MASS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL SKELETAL MUSCLE MASS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL VISCERAL FAT LEVEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL VISCERAL FAT LEVEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL VISCERAL FAT LEVEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BLUETOOTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BLUETOOTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BLUETOOTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL CLOUD-CONNECTED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL CLOUD-CONNECTED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL CLOUD-CONNECTED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL USB MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL USB MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL USB MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL WI-FI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL WI-FI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL WI-FI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL OFFLINE CHANNEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL OFFLINE CHANNEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL OFFLINE CHANNEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL ONLINE CHANNEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL ONLINE CHANNEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ONLINE CHANNEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL COMPANY WEBSITE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL COMPANY WEBSITE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL COMPANY WEBSITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL ECOMMERCE WEBSITE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL ECOMMERCE WEBSITE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL ECOMMERCE WEBSITE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL CARDIOLOGY & HEART FAILURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL CARDIOLOGY & HEART FAILURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL CARDIOLOGY & HEART FAILURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL ONCOLOGY & CACHEXIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL ONCOLOGY & CACHEXIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL ONCOLOGY & CACHEXIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL RENAL CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL RENAL CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL RENAL CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL NUTRITION & DIETETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL NUTRITION & DIETETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL NUTRITION & DIETETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL OBESITY & WEIGHT MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL OBESITY & WEIGHT MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL OBESITY & WEIGHT MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL PEDIATRIC GROWTH ASSESSMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL PEDIATRIC GROWTH ASSESSMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL PEDIATRIC GROWTH ASSESSMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL POPULATION HEALTH SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL POPULATION HEALTH SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL POPULATION HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL PREOPERATIVE & POSTOPERATIVE ASSESSMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL PREOPERATIVE & POSTOPERATIVE ASSESSMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL PREOPERATIVE & POSTOPERATIVE ASSESSMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL BARIATRIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL BARIATRIC SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL BARIATRIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL REHABILITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL REHABILITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL REMOTE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL REMOTE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL REMOTE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL SARCOPENIA & FRAILTY SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL SARCOPENIA & FRAILTY SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL SARCOPENIA & FRAILTY SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL SPORTS PERFORMANCE & TRAINING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL SPORTS PERFORMANCE & TRAINING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL SPORTS PERFORMANCE & TRAINING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL CORPORATE & COMMERCIAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL CORPORATE & COMMERCIAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL CORPORATE & COMMERCIAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL FITNESS & WELLNESS CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL FITNESS & WELLNESS CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL FITNESS & WELLNESS CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL HEALTHCARE & MEDICAL FACILITIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL HEALTHCARE & MEDICAL FACILITIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL HEALTHCARE & MEDICAL FACILITIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL BARIATRIC & WEIGHT MANAGEMENT CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL BARIATRIC & WEIGHT MANAGEMENT CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL BARIATRIC & WEIGHT MANAGEMENT CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL ENDOCRINOLOGY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL ENDOCRINOLOGY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL ENDOCRINOLOGY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL NUTRITION & DIETETICS CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL NUTRITION & DIETETICS CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL NUTRITION & DIETETICS CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL REHABILITATION CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL REHABILITATION CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL REHABILITATION CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL HOME & INDIVIDUAL USERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL HOME & INDIVIDUAL USERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL HOME & INDIVIDUAL USERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL PUBLIC HEALTH & GOVERNMENT ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL PUBLIC HEALTH & GOVERNMENT ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL PUBLIC HEALTH & GOVERNMENT ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL RESEARCH & ACADEMIC INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL RESEARCH & ACADEMIC INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL RESEARCH & ACADEMIC INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL SPORTS & PERFORMANCE INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL SPORTS & PERFORMANCE INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 202. GLOBAL SPORTS & PERFORMANCE INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC BODY COMPOSITION ANALYZER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC BODY COMPOSITION ANALYZER MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC BODY COMPOSITION ANALYZER MARKET SIZE, BY DUAL-ENERGY X-RAY ABSORPTIOMETRY (DXA), 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC BODY COMPOSITION ANALYZER MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC BODY COMPOSITION ANALYZER MARKET SIZE, BY PORTABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC BODY COMPOSITION ANALYZER MARKET SIZE, BY MEASUREMENT TYPE, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC BODY COMPOSITION ANALYZER MARKET SIZE, BY PARAMETER MEASURED, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC BODY COMPOSITION ANALYZER MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC BODY COMPOSITION ANALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC BODY COMPOSITION ANALYZER MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC BODY COMPOSITION ANALYZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. ASIA-PACIFIC BODY COMPOSITION ANALYZER MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 216. ASIA-PACIFIC BODY COMPOSITION ANALYZER MARKET SIZE, BY PREOPERATIVE & POSTOPERATIVE ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC BODY COMPOSITION ANALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 218. ASIA-PACIFIC BODY COMPOSITION ANALYZER MARKET SIZE, BY HEALTHCARE & MEDICAL FACILITIES, 2018-2032 (USD MILLION)
TABLE 219. ASIA-PACIFIC BODY COMPOSITION ANALYZER MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 220. EUROPE BODY COMPOSITION ANALYZER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 221. EUROPE BODY COMPOSITION ANALYZER MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
TABLE 222. EUROPE BODY COMPOSITION ANALYZER MARKET SIZE, BY DUAL-ENERGY X-RAY ABSORPTIOMETRY (DXA), 2018-2032 (USD MILLION)
TABLE 223. EUROPE BODY COMPOSITION ANALYZER MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 224. EUROPE BODY COMPOSITION ANALYZER MARKET SIZE, BY PORTABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 225. EUROPE BODY COMPOSITION ANALYZER MARKET SIZE, BY MEASUREMENT TYPE, 2018-2032 (USD MILLION)
TABLE 226. EUROPE BODY COMPOSITION ANALYZER MARKET SIZE, BY PARAMETER MEASURED, 2018-2032 (USD MILLION)
TABLE 227. EUROPE BODY COMPOSITION ANALYZER MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 228. EUROPE BODY COMPOSITION ANALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 229. EUROPE BODY COMPOSITION ANALYZER MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
TABLE 230. EUROPE BODY COMPOSITION ANALYZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. EUROPE BODY COMPOSITION ANALYZER MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 232. EUROPE BODY COMPOSITION ANALYZER MARKET SIZE, BY PREOPERATIVE & POSTOPERATIVE ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 233. EUROPE BODY COMPOSITION ANALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 234. EUROPE BODY COMPOSITION ANALYZER MARKET SIZE, BY HEALTHCARE & MEDICAL FACILITIES, 2018-2032 (USD MILLION)
TABLE 235. EUROPE BODY COMPOSITION ANALYZER MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 236. NORTH AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 237. NORTH AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
TABLE 238. NORTH AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY DUAL-ENERGY X-RAY ABSORPTIOMETRY (DXA), 2018-2032 (USD MILLION)
TABLE 239. NORTH AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 240. NORTH AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY PORTABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 241. NORTH AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY MEASUREMENT TYPE, 2018-2032 (USD MILLION)
TABLE 242. NORTH AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY PARAMETER MEASURED, 2018-2032 (USD MILLION)
TABLE 243. NORTH AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 244. NORTH AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 245. NORTH AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
TABLE 246. NORTH AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 247. NORTH AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 248. NORTH AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY PREOPERATIVE & POSTOPERATIVE ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 249. NORTH AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 250. NORTH AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY HEALTHCARE & MEDICAL FACILITIES, 2018-2032 (USD MILLION)
TABLE 251. NORTH AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 252. AFRICA BODY COMPOSITION ANALYZER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 253. AFRICA BODY COMPOSITION ANALYZER MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
TABLE 254. AFRICA BODY COMPOSITION ANALYZER MARKET SIZE, BY DUAL-ENERGY X-RAY ABSORPTIOMETRY (DXA), 2018-2032 (USD MILLION)
TABLE 255. AFRICA BODY COMPOSITION ANALYZER MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 256. AFRICA BODY COMPOSITION ANALYZER MARKET SIZE, BY PORTABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 257. AFRICA BODY COMPOSITION ANALYZER MARKET SIZE, BY MEASUREMENT TYPE, 2018-2032 (USD MILLION)
TABLE 258. AFRICA BODY COMPOSITION ANALYZER MARKET SIZE, BY PARAMETER MEASURED, 2018-2032 (USD MILLION)
TABLE 259. AFRICA BODY COMPOSITION ANALYZER MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 260. AFRICA BODY COMPOSITION ANALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 261. AFRICA BODY COMPOSITION ANALYZER MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
TABLE 262. AFRICA BODY COMPOSITION ANALYZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 263. AFRICA BODY COMPOSITION ANALYZER MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 264. AFRICA BODY COMPOSITION ANALYZER MARKET SIZE, BY PREOPERATIVE & POSTOPERATIVE ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 265. AFRICA BODY COMPOSITION ANALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 266. AFRICA BODY COMPOSITION ANALYZER MARKET SIZE, BY HEALTHCARE & MEDICAL FACILITIES, 2018-2032 (USD MILLION)
TABLE 267. AFRICA BODY COMPOSITION ANALYZER MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 268. LATIN AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 269. LATIN AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
TABLE 270. LATIN AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY DUAL-ENERGY X-RAY ABSORPTIOMETRY (DXA), 2018-2032 (USD MILLION)
TABLE 271. LATIN AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 272. LATIN AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY PORTABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 273. LATIN AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY MEASUREMENT TYPE, 2018-2032 (USD MILLION)
TABLE 274. LATIN AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY PARAMETER MEASURED, 2018-2032 (USD MILLION)
TABLE 275. LATIN AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 276. LATIN AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 277. LATIN AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
TABLE 278. LATIN AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 279. LATIN AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 280. LATIN AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY PREOPERATIVE & POSTOPERATIVE ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 281. LATIN AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 282. LATIN AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY HEALTHCARE & MEDICAL FACILITIES, 2018-2032 (USD MILLION)
TABLE 283. LATIN AMERICA BODY COMPOSITION ANALYZER MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 284. MIDDLE EAST BODY COMPOSITION ANALYZER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 285. MIDDLE EAST BODY COMPOSITION ANALYZER MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
TABLE 286. MIDDLE EAST BODY COMPOSITION ANALYZER MARKET SIZE, BY DUAL-ENERGY X-RAY ABSORPTIOMETRY (DXA), 2018-2032 (USD MILLION)
TABLE 287. MIDDLE EAST BODY COMPOSITION ANALYZER MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 288. MIDDLE EAST BODY COMPOSITION ANALYZER MARKET SIZE, BY PORTABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 289. MIDDLE EAST BODY COMPOSITION ANALYZER MARKET SIZE, BY MEASUREMENT TYPE, 2018-2032 (USD MILLION)
TABLE 290. MIDDLE EAST BODY COMPOSITION ANALYZER MARKET SIZE, BY PARAMETER MEASURED, 2018-2032 (USD MILLION)
TABLE 291. MIDDLE EAST BODY COMPOSITION ANALYZER MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 292. MIDDLE EAST BODY COMPOSITION ANALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 293. MIDDLE EAST BODY COMPOSITION ANALYZER MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
TABLE 294. MIDDLE EAST BODY COMPOSITION ANALYZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 295. MIDDLE EAST BODY COMPOSITION ANALYZER MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 296. MIDDLE EAST BODY COMPOSITION ANALYZER MARKET SIZE, BY PREOPERATIVE & POSTOPERATIVE ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 297. MIDDLE EAST BODY COMPOSITION ANALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 298. MIDDLE EAST BODY COMPOSITION ANALYZER MARKET SIZE, BY HEALTHCARE & MEDICAL FACILITIES, 2018-2032 (USD MILLION)
TABLE 299. MIDDLE EAST BODY COMPOSITION ANALYZER MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 300. GLOBAL BODY COMPOSITION ANALYZER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 301. NATO BODY COMPOSITION ANALYZER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 302. NATO BODY COMPOSITION ANALYZER MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
TABLE 303. NATO BODY COMPOSITION ANALYZER MARKET SIZE, BY DUAL-ENERGY X-RAY ABSORPTIOMETRY (DXA), 2018-2032 (USD MILLION)
TABLE 304. NATO BODY COMPOSITION ANALYZER MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 305. NATO BODY COMPOSITION ANALYZER MARKET SIZE, BY PORTABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 306. NATO BODY COMPOSITION ANALYZER MARKET SIZE, BY MEASUREMENT TYPE, 2018-2032 (USD MILLION)
TABLE 307. NATO BODY COMPOSITION ANALYZER MARKET SIZE, BY PARAMETER MEASURED, 2018-2032 (USD MILLION)
TABLE 308. NATO BODY COMPOSITION ANALYZER MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 309. NATO BODY COMPOSITION ANALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 310. NATO BODY COMPOSITION ANALYZER MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
TABLE 311. NATO BODY COMPOSITION ANALYZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 312. NATO BODY COMPOSITION ANALYZER MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 313. NATO BODY COMPOSITION ANALYZER MARKET SIZE, BY PREOPERATIVE & POSTOPERATIVE ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 314. NATO BODY COMPOSITION ANALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 315. NATO BODY COMPOSITION ANALYZER MARKET SIZE, BY HEALTHCARE & MEDICAL FACILITIES, 2018-2032 (USD MILLION)
TABLE 316. NATO BODY COMPOSITION ANALYZER MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 317. G7 BODY COMPOSITION ANALYZER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 318. G7 BODY COMPOSITION ANALYZER MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
TABLE 319. G7 BODY COMPOSITION ANALYZER MARKET SIZE, BY DUAL-ENERGY X-RAY ABSORPTIOMETRY (DXA), 2018-2032 (USD MILLION)
TABLE 320. G7 BODY COMPOSITION ANALYZER MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 321. G7 BODY COMPOSITION ANALYZER MARKET SIZE, BY PORTABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 322. G7 BODY COMPOSITION ANALYZER MARKET SIZE, BY MEASUREMENT TYPE, 2018-2032 (USD MILLION)
TABLE 323. G7 BODY COMPOSITION ANALYZER MARKET SIZE, BY PARAMETER MEASURED, 2018-2032 (USD MILLION)
TABLE 324. G7 BODY COMPOSITION ANALYZER MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 325. G7 BODY COMPOSITION ANALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 326. G7 BODY COMPOSITION ANALYZER MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
TABLE 327. G7 BODY COMPOSITION ANALYZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 328. G7 BODY COMPOSITION ANALYZER MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 329. G7 BODY COMPOSITION ANALYZER MARKET SIZE, BY PREOPERATIVE & POSTOPERATIVE ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 330. G7 BODY COMPOSITION ANALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 331. G7 BODY COMPOSITION ANALYZER MARKET SIZE, BY HEALTHCARE & MEDICAL FACILITIES, 2018-2032 (USD MILLION)
TABLE 332. G7 BODY COMPOSITION ANALYZER MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 333. EUROPEAN UNION BODY COMPOSITION ANALYZER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 334. EUROPEAN UNION BODY COMPOSITION ANALYZER MARKET SIZE, BY ANALYZER TYPE, 2018-2032 (USD MILLION)
TABLE 335. EUROPEAN UNION BODY COMPOSITION ANALYZER MARKET SIZE, BY DUAL-ENERGY X-RAY ABSORPTIOMETRY (DXA), 2018-2032 (USD MILLION)
TABLE 336. EUROPEAN UNION BODY COMPOSITION ANALYZER MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 337. EUROPEAN UNION BODY COMPOSITION ANALYZER MARKET SIZE, BY PORTABLE DEVICES, 2018-2032 (USD MILLION)
TABLE 338. EUROPEAN UNION BODY COMPOSITION ANALYZER MARKET SIZE, BY MEASUREMENT TYPE, 2018-2032 (USD MILLION)
TABLE 339. EUROPEAN UNION BODY COMPOSITION ANALYZER MARKET SIZE, BY PARAMETER MEASURED, 2018-2032 (USD MILLION)
TABLE 340. EUROPEAN UNION BODY COMPOSITION ANALYZER MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
TABLE 341. EUROPEAN UNION BODY COMPOSITION ANALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 342. EUROPEAN UNION BODY COMPOSITION ANALYZER MARKET SIZE, BY ONLINE CHANNEL, 2018-2032 (USD MILLION)
TABLE 343. EUROPEAN UNION BODY COMPOSITION ANALYZER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 344. EUROPEAN

Companies Mentioned

  • A&D Company, Limited
  • AccuFitness, LLC
  • ACCUNIQ by SELVAS Healthcare, Inc.
  • AKERN SRL
  • anovator
  • Beurer GmbH
  • BioTekna Limited.
  • Biowave Healthcare
  • Bodivis by Tongyong Tizhi Health Technology Co.,Ltd
  • Bodystat Limited
  • Charder Electronic Co. Ltd
  • COSMED Srl
  • GE Healthcare, Inc.
  • Hologic, Inc.
  • Hume Health LLC
  • iHealth Labs Inc.
  • ImpediMed Limited
  • Inbody Co. Ltd.
  • Jawon Medical Co., Ltd.
  • Joicom Corporation d/b/a Renpho
  • medisana GmbH
  • Omron Corporation
  • RJL Systems, Inc.
  • Seca GmbH & Co. KG
  • Shenzhen Sonka Medical Technology Co., Limited
  • Tanita Corporation
  • Terraillon S.A.
  • Zimed Healthcare LLC

Table Information

Report AttributeDetails
No. of Pages192
PublishedJuly 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 901.73 Million
Forecasted Market Value ( USD ) by 2032 $ 1520 Million
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

DXA Body Composition Analyzer Market - Global Forecast 2025-2030 - Product Image

DXA Body Composition Analyzer Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Medical Grade Body Composition Analyzer Market - Global Forecast 2025-2030 - Product Image

Medical Grade Body Composition Analyzer Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Body Composition Analyzers Market Report by Product, End User, and Region 2026-2034 - Product Image

Body Composition Analyzers Market Report by Product, End User, and Region 2026-2034

  • Report
  • 137 Pages
  • Global
From
Smart Weight, Body Composition, and BMI Scales - Global Strategic Business Report - Product Image

Smart Weight, Body Composition, and BMI Scales - Global Strategic Business Report

  • Report
  • 234 Pages
  • Global
From
Body Composition Analyzers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Body Composition Analyzers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 185 Pages
  • Global
From

About the Body Composition Analyzer Market

The Body Composition Analyzer market within the Healthcare Services sector is a rapidly growing industry. It is used to measure body composition, which is the proportion of fat and lean mass in the body. This technology is used to assess the health of individuals and to monitor changes in body composition over time. It is also used to diagnose and monitor conditions such as obesity, diabetes, and cardiovascular disease. Body Composition Analyzers are used in a variety of healthcare settings, including hospitals, clinics, and fitness centers. They are also used in research studies to assess the effects of diet and exercise on body composition. Some of the major companies in the Body Composition Analyzer market include Tanita Corporation, InBody Co., Omron Healthcare, GE Healthcare, and Fit3D. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.